Thymoquinone suppresses metastasis of melanoma cells by inhibition of NLRP3 inflammasome

Toxicology and Applied Pharmacology

Volumn 270, Issue 1, 2013, Pages 70-76

  Ahmad, Israr ^a   Muneer, Kashiff M ^a   Tamimi, Iman A ^a   Chang, Michelle E ^a   Ata, Muhammad O ^a   Yusuf, Nabiha ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Inflammasome; Melanoma; Metastasis; Thymoquinone

Indexed keywords

CRYOPYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; REACTIVE OXYGEN METABOLITE; THYMOQUINONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLACK CUMIN; CANCER IMMUNOTHERAPY; CARCINOGENESIS; CELL ASSAY; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN TARGETING;

ANIMALS; BENZOQUINONES; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; HUMANS; INFLAMMASOMES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL;

EID: 84877317367     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.03.027     Document Type: Article

References (30)

1. Abdelmeguid N.E., Fakhoury R., Kamal S.M., Al Wafai R.J. Effects of Nigella sativa and thymoquinone on biochemical and subcellular changes in pancreatic β-cells of streptozotocin-induced diabetic rats. J. Diabetes 2010, 2(4):256-266. ([PubMed: 20923501]).
2. Ahmad I., Jimenez H., Yaacob N.S., Yusuf N. Tualang honey protects keratinocytes from ultraviolet radiation-induced inflammation and DNA damage. Photochem. Photobiol. 2012, 88(5):1198-1204. ([PubMed: 22276569]).
3. Banerjee S., Padhye S., Azmi A., Wang Z., Philip P.A., Kucuk O., Sarkar F.H., Mohammad R.M. Review on molecular and therapeutic potential of thymoquinone in cancer. Nutr. Cancer 2010, 62(7):938-946. ([PubMed: 20924969]).
4. Chow M.T., Sceneay J., Paget C., Wong C.S., Duret H., Tschopp J., Möller A., Smyth M.J. NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases. Cancer Res. 2012, 72(22):5721-5732. ([PubMed: 22986739]).
5. Dunn J.H., Ellis L.Z., Fujita M. Inflammasomes as molecular mediators of inflammation and cancer: potential role in melanoma. Cancer Lett. 2012, 314(1):24-33. ([PubMed: 22050907]).
6. Ellis L.Z., Liu W., Luo Y., Okamoto M., Qu D., Dunn J.H., Fujita M. Green tea polyphenol epigallocatechin-3-gallate suppresses melanoma growth by inhibiting inflammasome and IL-1β secretion. Biochem. Biophys. Res. Commun. 2011, 414(3):551-556. ([PubMed: 21982776]).
7. Faustin B., Lartigue L., Bruey J.M., Luciano F., Sergienko E., Bailly-Maitre B., Volkmann N., Hanein D., Rouiller I., Reed J.C. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol. Cell 2007, 25(5):713-724. ([PubMed: 17349957]).
8. Fidler I.J., Hart I.R. Biological diversity in metastatic neoplasms: origins and implications. Science 1982, 217(4564):998-1003. ([PubMed: 7112116]).
9. Franchi L., Eigenbrod T., Muñoz-Planillo R., Nuñez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat. Immunol. 2009, 10(3):241-247. ([PubMed: 19221555]).
10. Garbe C., Peris K., Hauschild A., Saiag P., Middleton M., Spatz A., Grob J.J., Malvehy J., Newton-Bishop J., Stratigos A., Pehamberger H., Eggermont A.M. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2012. Eur. J. Cancer 2012, 48(15):2375-2390. ([PubMed: 22981501]).
11. Jafri S.H., Glass J., Shi R., Zhang S., Prince M., Kleiner-Hancock H. Thymoquinone and cisplatin as a therapeutic combination in lung cancer: in vitro and in vivo. J. Exp. Clin. Cancer Res. 2010, 29:87. ([PubMed: 20594324]).
12. Kanter M. Nigella sativa and derived thymoquinone prevents hippocampal neurodegeneration after chronic toluene exposure in rats. Neurochem. Res. 2008, 33(3):579-588. (PubMed: 17929168).
13. Lamkanfi M. Emerging inflammasome effector mechanisms. Nat. Rev. Immunol. 2011, 11(3):213-220. ([PubMed: 21350580]).
14. Lamkanfi M., Dixit V.M. Inflammasomes: guardians of cytosolic sanctity. Immunol. Rev. 2009, 227(1):95-105. ([PubMed: 19120479]).
15. Lamkanfi M., Mueller J.L., Vitari A.C., Misaghi S., Fedorova A., Deshayes K., Lee W.P., Hoffman H.M., Dixit V.M. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J. Cell Biol. 2009, 187(1):61-70. ([PubMed: 19805629]).
16. Liu W., Luo Y., Dunn J.H., Norris D.A., Dinarello C.A., Fujita M. Dual role of apoptosis-associated speck-like protein containing a CARD (ASC) in tumorigenesis of human melanoma. J. Invest. Dermatol 2012, ([PubMed: 22931929]). 10.1038/jid.2012.317.
17. MacKie R.M., Hauschild A., Eggermont A.M. Epidemiology of invasive cutaneous melanoma. Ann. Oncol. 2009, 20(Suppl. 6vi1-7). ([PubMed: 19617292]).
18. Okamoto M., Liu W., Luo Y., Tanaka A., Cai X., Norris D.A., Dinarello C.A., Fujita M. Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1β. J. Biol. Chem. 2010, 285(9):6477-6488. ([PubMed: 20038581]).
19. Opdenakker G., Van Damme J. Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer. Cytokine 1992, 4(4):251-258. ([PubMed: 1515548]).
20. Piccini A., Carta S., Tassi S., Lasiglié D., Fossati G., Rubartelli A. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(23):8067-8072. ([PubMed: 18523012]).
21. Raman D., Baugher P.J., Thu Y.M., Richmond A. Role of chemokines in tumor growth. Cancer Lett. 2007, 256(2):137-165. ([PubMed: 17629396]).
22. Sahoo M., Ceballos-Olvera I., del Barrio L., Re F. Role of the inflammasome, IL-1β, and IL-18 in bacterial infections. Sci. World J. 2011, 11:2037-2050. ([PubMed: 22125454]).
23. Saijo Y., Tanaka M., Miki M., Usui K., Suzuki T., Maemondo M., Hong X., Tazawa R., Kikuchi T., Matsushima K., Nukiwa T. Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction. J. Immunol. 2002, 169(1):469-475. ([PubMed: 12077278]).
24. Tsai P.Y., Ka S.M., Chang J.M., Chen H.C., Shui H.A., Li C.Y., Hua K.F., Chang W.L., Huang J.J., Yang S.S., Chen A. Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation. Free Radic. Biol. Med. 2011, 51(3):744-754. ([PubMed: 21641991]).
25. Tschopp J., Schroder K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?. Nat. Rev. Immunol. 2010, 10(3):210-215. ([PubMed: 20168318]).
26. Vaid M., Prasad R., Sun Q., Katiyar S.K. Silymarin targets β-catenin signaling in blocking migration/invasion of human melanoma cells. PLoS One 2011, 6(7):e23000. (Epub 2011 Jul 28 [PubMed: 21829575]).
27. Van de Veerdonk F.L., Netea M.G., Dinarello C.A., Joosten L.A. Inflammasome activation and IL-1β and IL-18 processing during infection. Trends Immunol. 2011, 32(3):110-116. ([PubMed: 21333600]).
28. Verma D., Bivik C., Farahani E., Synnerstad I., Fredrikson M., Enerbäck C., Rosdahl I., Söderkvist P. Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma. Pigment Cell Melanoma Res. 2012, 25(4):506-513. ([PubMed: 22524199]).
29. Woo C.C., Kumar A.P., Sethi G., Tan K.H. Thymoquinone: potential cure for inflammatory disorders and cancer. Biochem. Pharmacol. 2012, 83(4):443-451. ([PubMed: 22005518]).
30. Yazdi A.S., Drexler S.K., Tschopp J. The role of the inflammasome in nonmyeloid cells. J. Clin. Immunol. 2010, 30(5):623-627. ([PubMed: 20582456]).